Skip to main content

Daily ReportOct 5, 2026

Sepsis, October 5 edition

We read 19 papers and selected 3.

Summary

Today’s most impactful sepsis research spans three complementary areas: evaluation of a widely implemented pediatric sepsis alert, immune-based prediction of deterioration in transplant recipients, and individualized blood-pressure target interpretation in elderly septic shock. Collectively, these studies emphasize that sepsis care requires validation of screening tools, biologically informed risk stratification, and context-specific hemodynamic management rather than uniform protocols.

Research Themes

  • External validation and equity of sepsis screening algorithms
  • Immune biosignatures for prognostic prediction
  • Individualized hemodynamic targets in septic shock

Selected Articles

1. Evaluation of a Commercial Pediatric Sepsis Early Detection Alert in the Emergency Department.

80.5Evidence level IIICohort
JAMA pediatrics2026PMID: 42832216

This retrospective multicenter cohort evaluated the Epic Pediatric Sepsis Early Detection Model across 166,943 pediatric emergency department encounters, including 189 sepsis cases. Sensitivity for sepsis was only 36%, positive predictive value was 3%, and sensitivity before Phoenix sepsis criteria were met was 30%. Performance was worse in Black children, children younger than 5 years, and nontertiary settings.

Impact: The study provides an independent, large-scale evaluation of a commercially deployed sepsis alert and demonstrates that implementation does not guarantee clinically useful early detection. The observed subgroup disparities also identify an important patient-safety and health-equity concern.

Clinical Implications: Hospitals should not assume that the PESM alert reliably rules in or detects pediatric sepsis early. Local validation, prospective monitoring, subgroup-specific performance assessment, and complementary clinician-led evaluation are needed before using the alert to guide escalation or reassure clinicians that sepsis is unlikely.

Key Findings

  • Among 166,943 pediatric emergency department encounters, 189 sepsis cases occurred within 24 hours.
  • PESM sensitivity was 36%, positive predictive value was 3%, and negative predictive value exceeded 99%.
  • Sensitivity before sepsis onset was 30% and was at least 10 percentage points lower in Black children, children younger than 5 years, and nontertiary settings.

Methodological Strengths

  • Large multicenter cohort involving eight emergency departments and more than 166,000 pediatric encounters.
  • Used Phoenix sepsis criteria and separately assessed detection before formal sepsis onset.
  • Evaluated clinically relevant demographic and institutional subgroups, including racial and age-related performance.

Limitations

  • Retrospective design may be affected by documentation quality, missing data, and ascertainment bias.
  • Only 189 sepsis cases occurred, resulting in imprecise subgroup estimates.
  • The study evaluated alert performance rather than whether alert implementation changed treatment or patient outcomes.

Future Directions: Prospective multicenter evaluations should compare alternative pediatric sepsis algorithms, assess calibration across demographic groups, investigate causes of low sensitivity, and test whether revised or ensemble systems improve outcomes without increasing unnecessary treatment.

IMPORTANCE: Screening tools have been implemented with the goal of improving early detection of pediatric sepsis, with limited evidence of effectiveness. The Epic Systems Pediatric Sepsis Early Detection Model (PESM) and its associated clinical alert have been widely implemented in emergency departments (EDs) in the US but have not undergone independent evaluation. OBJECTIVE: To evaluate the diagnostic characteristics of the Epic PESM for (1) identifying sepsis and (2) identifying sepsis before patients met Phoenix sepsis criteria. DESIGN, SETTING, AND PARTICIPANTS: This retrospective multicenter cohort study of pediatric ED encounters was conducted across 8 EDs within a New York health system from January 2024 through June 2025. Children younger than 18 years were included; behavioral health encounters and ED deaths within 1 hour of arrival were excluded.

2. Host Immune Biosignatures Predict Septic Shock and Mortality in Solid Organ Transplant Recipients With Gram-Negative Bacteremia.

76.0Evidence level IIICohort
The Journal of infectious diseases2026PMID: 42831489

In 169 solid organ transplant recipients with Gram-negative bacteremia, 45 experienced septic shock or death. A model combining clinical variables with two principal components derived from 27 immune mediators improved discrimination compared with the clinical model alone, increasing the area under the curve from 0.70 to 0.84. Distinct inflammatory and adaptive immune patterns were associated with adverse and favorable outcomes, respectively.

Impact: The study links measurable host immune states to clinically important outcomes in a high-risk population and demonstrates added predictive value beyond routine clinical variables. It provides a mechanistic framework for future immune-guided monitoring and treatment trials.

Clinical Implications: Immune profiling may eventually help identify transplant recipients with Gram-negative bacteremia who require intensified monitoring, earlier organ-support planning, or enrollment in targeted immunomodulatory trials. The findings are not yet sufficient to guide individual treatment because external validation and prospective clinical utility studies are needed.

Key Findings

  • Among 169 solid organ transplant recipients with Gram-negative bacteremia, 45 patients (26.6%) developed septic shock or died.
  • Adding two immune principal components to clinical variables improved the area under the curve from 0.70 to 0.84 (P < .001).
  • A proinflammatory and anti-inflammatory dysregulation pattern was associated with adverse outcomes, whereas coordinated Th1, Th17, and humoral immunity was associated with favorable outcomes.

Methodological Strengths

  • Prospective plasma collection in a clinically well-defined high-risk population.
  • Broad measurement of 27 cytokines, chemokines, and immunoglobulin markers representing multiple immune pathways.
  • Internal validation using repeated 10-fold cross-validation and direct comparison of clinical versus clinical-immunologic models.

Limitations

  • The sample size was modest and derived from a specialized solid organ transplant population, limiting generalizability.
  • Validation was internal; external validation and prospective recalibration are required.
  • Principal components may improve prediction but are less readily interpretable and actionable than a small set of individual biomarkers.

Future Directions: Future studies should externally validate the biosignature in diverse transplant programs, establish timing and assay standardization, assess incremental clinical utility, and test whether immune-guided interventions improve outcomes without increasing infection or rejection risk.

BACKGROUND: The aim of this study was to determine whether the addition of immunologic biosignatures to a predictive model based solely on clinical data could improve the model's ability to predict patient outcome among solid organ transplant (SOT) recipients with gram-negative bacteremia (GNB). METHODS: Plasma was prospectively collected from SOT recipients with GNB. Twenty-seven cytokines, chemokines, and immunoglobulin levels were quantified. Two logistic regression models were specified: a clinical model including age, transplanted organ, and time since transplant and a clinical-immunologic model that additionally incorporated the first two principal components. Model performance was evaluated using area under the curve (AUC). Internal validation was performed by repeated 10-fold cross-validation. RESULTS: Of 169 SOT recipients with GNB, 45 (26.6%) experienced an adverse outcome (septic shock or death). When compared with the clinical model alone, the clinical-immunologic model demonstrated superior discrimination (AUC, 0.70 vs 0.84; P < .001).

3. High blood pressure-targeted management associated with reduced benefits of higher body mass index in elderly patients with septic shock: a post hoc analysis of a multicenter randomized controlled trial.

71.5Evidence level IIRCT
Annals of intensive care2026PMID: 42831066

This post hoc analysis included 489 adults aged 65 years or older with septic shock randomized to a mean arterial pressure target of 65–70 mmHg or 80–85 mmHg. Under the standard target, mortality decreased across increasing body mass index categories, but this association disappeared under the high target. High-target management was associated with higher mortality in both underweight and higher-body-mass-index groups compared with normal body mass index.

Impact: The analysis suggests that the prognostic meaning of body habitus in elderly septic shock is not fixed but may depend on hemodynamic management. It raises a clinically testable hypothesis that higher blood-pressure targets can negate or reverse the observed obesity paradox.

Clinical Implications: Clinicians should be cautious about applying high mean arterial pressure targets uniformly to elderly patients with septic shock, particularly those with low or high body mass index. The findings support individualized assessment of perfusion, fluid dosing, vasopressor exposure, frailty, and comorbidity rather than using body mass index alone to guide therapy.

Key Findings

  • Among 489 elderly patients with septic shock, 245 were assigned to a mean arterial pressure target of 65–70 mmHg and 244 to 80–85 mmHg.
  • In the standard-target group, mortality decreased across increasing body mass index categories, whereas no trend was observed in the high-target group.
  • In the high-target group, underweight and higher-body-mass-index patients had higher mortality than normal-body-mass-index patients, with adjusted hazard ratios of 1.74 and 1.72, respectively.

Methodological Strengths

  • Uses data from a multicenter randomized controlled trial, preserving the randomized hemodynamic treatment allocation.
  • Prespecified clinical adjustment included age, sex, APACHE II score, Clinical Frailty Scale, and infection site.
  • Examines interaction between blood-pressure target and body mass index rather than assessing either factor in isolation.

Limitations

  • This was a post hoc subgroup and interaction analysis, so the findings are hypothesis-generating rather than definitive.
  • The original trial was conducted in 29 Japanese centers and may not generalize to younger patients or other healthcare systems.
  • The trial was not registered for this post hoc analysis, and residual confounding related to fluid and vasopressor management remains possible.

Future Directions: Prospective trials should test individualized mean arterial pressure targets stratified by age, body mass index, frailty, chronic hypertension, and perfusion phenotype. Mechanistic analyses should determine whether differences in fluid balance, vasopressor exposure, cardiac reserve, or microcirculatory function explain the interaction.

BACKGROUND: Body mass index (BMI) is an important prognostic factor in sepsis, and an obesity paradox has been reported. A higher mean arterial pressure (MAP) target has been associated with worse outcomes in elderly patients with septic shock. However, whether MAP target strategy alters the association between BMI and outcomes in this population is unknown. METHODS: We conducted a post hoc analysis of the OPTPRESS trial, a multicenter randomized controlled trial at 29 Japanese centers reporting worse outcomes with a high MAP target in elderly patients with septic shock. A total of 489 patients aged ≥65 years with septic shock were assigned to a control MAP target of 65-70 mmHg (n = 245) or high target of 80-85 mmHg (n = 244). Patients were categorized using Asian BMI cutoffs into underweight (<18.5 kg/m